wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q37604501-252704DF-B853-4338-801A-EE5BFE3A0D56
Q37604501-252704DF-B853-4338-801A-EE5BFE3A0D56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-252704DF-B853-4338-801A-EE5BFE3A0D56
Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study.
P2860
Q37604501-252704DF-B853-4338-801A-EE5BFE3A0D56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q37604501-252704DF-B853-4338-801A-EE5BFE3A0D56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f047df701f73c214aba2e5fbaa813317a3c03ae9
P2860
Proposal for a new nomenclature of disease-modifying antirheumatic drugs.